Abstract:Objects To evaluate the therapeutic efficacy of combination therapy of plasma perfusion(PP) and plasma exchange(PE) on patients with liver failure and hyperbilirubinemia.Methods Fifty-one patients(totally 66 person-times) with liver failure and hyperbilirubinemia received a combination therapy of PP and PE with a small amount of plasma.Serum TBIL,TBA,PTA,ALB and WBC were measured before treatment,at the end of treatment and at hour 48 post-treatment.Adverse reactions were closely observed.Thirty-six patients(totally 79 person-times) who simply received PE were taken as the control group.Results The total effective rate of combination therapy group was 60.87%,higher than that of PE group(52.78%),but the difference was not statistically significant between both groups(P >0.05).Serum TBIL levels at the end of treatment and at hour 48 post-treatment were significantly lower than those before treatment in the patients of both groups(P<0.05),and the levels decreased more sharply in the patients of the combination therapy group than in the patients of PE group(P<0.05).The serum levels of TBA in the patients of both groups were lower at the end of treatment than those before treatment(P<0.05),but no significant differences were found between both groups(P>0.05).PTA values of the patients of both groups were higher at the end of treatment than before treatment(P<0.05).Compared with pretherapy,serum ALB and GLO levels in the patients of combination therapy group made no differences at the end of treatment and at hour 48 post-treatment,but those in the patients of PE group decreased significantly(P<0.05).Compared with pretherapy,there were no differences in WBC counts in the patients of both groups at the end of treatment and at hour 48 post-treatment,but PLT counts in the patients of both groups decreased significantly at the end of treatment(P<0.05).The average usage of plasma among the patients of combination therapy group was significantly lower than that among the patients of PE group.No severe adverse reactions were observed.Conclusion The combination therapy of PP and PE uses a smaller amount of plasma,and is safe and effective for the patients with liver failure and hyperbilirubinemia.

Efficacy of Plasma Exchange in Treatment of Patients with Liver Failure

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Changes in Peripheral CD4+CD25 high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment

Comparitive study of middle and mixed artificial livers in treatment of hepatic failure

Effects of Hemoperfusion Adsorption And/or Plasma Exchange in Treatment of Severe Viral Hepatitis: A Comparative Study

Assessment of the Combined Effect of Plasma Exchange and Plasma Perfusion on Patients with Severe Hepatitis Awaiting Orthotopic Liver Transplantation

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

Comparison of Plasma Exchange with Different Membrane Pore Sizes in the Treatment of Severe Viral Hepatitis

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

Untoward hematologic responses to the antithyroid compounds.

Effects of Plasma Exchange Combined with Continuous Renal Replacement Therapy on Acute Fatty Liver of Pregnancy.

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Effects of Plasma from Acute-on-chronic Liver Failure Patients on Immortalized Human Hepatocytes in Vitro.

Analysis of Clinical Effect of Continuous Plasma Diafiltration for the Therapy of Liver Failure

Plasma exchange treatment using MELD scoring system improve the prognosis of fulminant Hepatitis in Chinese patients

Therapeutic Plasma Exchange in Children With Acute and Acuteon-Chronic Liver Failure: A Single-Center Experience.

Combination therapy of plasma perfusion and plasma exchange in patients with liver failure and hyperbilirubinemia

The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis